Skip to main content
. 2021 Dec 29;157(3):221–230. doi: 10.1001/jamasurg.2021.6496

Table 2. Event Rates, Cumulative Incidence Estimates, and Hazard Ratios in Patients in the Surgical vs Control Group.

COVID-19–related outcome Surgical group (n = 2958) Control group (n = 8851) HR (95% CI)b P valueb
Event rate, No. (%)a Crude rate in patients with COVID-19, % Cumulative incidence at 12 mo (95% CI), % Event rate, No. (%)a Crude rate in patients with COVID-19, % Cumulative incidence at 12 mo (95% CI), %
Positive SARS-CoV-2 test result 206 (7.0) NA 9.1 (7.9-10.3) 578 (6.5) NA 8.7 (8.0-9.3) 1.03 (0.87-1.22) .71
Hospitalization 32 (1.1) 15.5 1.4 (0.9-1.9) 163 (1.8) 28.2 2.4 (2.1-2.8) 0.51 (0.35-0.76) <.001
Need for supplemental oxygen 19 (0.6) 9.2 0.8 (0.5-1.2) 129 (1.5) 22.3 1.9 (1.6-2.3) 0.37 (0.23-0.61) <.001
Severe COVID-19 infectionc 8 (0.3) 3.9 0.4 (0.1-0.7) 54 (0.6) 9.3 0.8 (0.6-1.0) 0.40 (0.18-0.86) .02
Death 2 (0.1) 1.0 0.1 (0-0.3) 21 (0.2) 3.6 0.3 (0.2-0.4) 0.27 (0.06-1.20) .09

Abbreviations: HR, hazard ratio; NA, not applicable.

a

Events occurred in a 12-month period, from March 1, 2020, to March 1, 2021, starting from the first COVID-19 diagnosis in the Cleveland Clinic Health System in March 2020.

b

HRs (95% CIs) and P values were from adjusted Cox proportional hazards regression models that compared the relative instantaneous risk of each outcome for the surgical vs control group. All baseline variables in Table 1 were adjusted for potential confounding.

c

Composite of intensive care unit admission, need for mechanical ventilation, or death.